Drug Shortage Report for ENGERIX-B
| Report ID | 267093 |
| Drug Identification Number | 02487020 |
| Brand name | ENGERIX-B |
| Common or Proper name | Hepatitis B vaccine (recombinant) |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 10MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 1s |
| ATC code | J07BC |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-09-08 |
| Estimated end date | 2025-11-17 |
| Actual end date | 2025-10-10 |
| Shortage status | Resolved |
| Updated date | 2025-10-11 |
| Company comments | Shortage impacts private market supply only. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-10-11 | English | Compare |
| v5 | 2025-10-10 | French | Compare |
| v4 | 2025-10-10 | English | Compare |
| v3 | 2025-09-12 | French | Compare |
| v2 | 2025-09-12 | English | Compare |
| v1 | 2025-09-12 | English | Compare |
Showing 1 to 6 of 6